Lastly, we identified six survival-related genes (EMP1, TPM1, NRP2, FGFR1, CAVIN1, and LATS2) and used this gene-set to group the bladder cancer patients into two clusters, while three survival-related genes (EMP1, FGFR1, and CAVIN1) were used to estimate the prognostic risk for the patients grouped in cluster 1. This evidence concerns the gene FGFR1 and urinary bladder carcinoma.